Local and systemic side effects of COVID-19 vaccine in Tunisian cancer patients: A prospective single center study.

Wala Ben Kridis-RejebOlfa BoudawaraAfef Khanfir

Published in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2024)

Our study showed that systemic side effects were more common after the first dose of Oxford/AstraZeneca vaccine compared to the Pfizer/BioNTech vaccine in cancer patient, with the predominance of any grade of local or systemic toxicity in women.

Keyphrases

coronavirus disease
sars cov
papillary thyroid
oxidative stress
polycystic ovary syndrome
squamous cell carcinoma
squamous cell
metabolic syndrome
pregnant women